Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 3 Not yet recruiting 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Recurrence 13 Multiple Myeloma 12 Lymphoma, B-Cell 12 Lymphoma, Non-Hodgkin 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma 7 Burkitt Lymphoma 7 Melanoma 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Nasopharyngeal Carcinoma 4 Myelodysplastic Syndromes 4 Lymphoma, T-Cell 4 Leukemia 3 Graft vs Host Disease 3 Uterine Cervical Neoplasms 2 Sarcoma, Synovial 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Glioblastoma 2

Interventions

Immunotherapy, Adoptive 2 flumatinib 1 fludarabine 1 Thiotepa 1 Sensitivity and Specificity 1 Imatinib Mesylate 1 Idarubicin 1 Diagnosis 1 Deferasirox 1 Decitabine 1 Daunorubicin 1 Cytarabine 1 Cladribine 1 Busulfan 1 Blood Specimen Collection 1 Azacitidine 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia, Myeloid × fludarabine × Clear all

NCT02333838 2018-08-13

TBF-Cord

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡